Search Results
Mar 16, 2026, 10:24 ET International Gate Control and AirportLabs Redefine Operational Precision at Chicago O'Hare Airport
Aviation (CDA), deployed two core systems, SkyCore AODB and Allegra RMS. These replaced legacy systems with a unified, real-time intelligence layer. Six months in, the systems are reshaping how one of the world's most complex airports operates day to day.
More news about: AirportLabs Limited
Mar 16, 2026, 10:20 ET Laronix Launches Voice Restoration Study for ICU Patients at Greater Baltimore Medical Center
to communicate in a critical care environment. Laronix is pleased to collaborate with the Milton J. Dance Jr. Center for this study."More than six million patients in the U.S are admitted to ICUs annually, and up to 40% are placed on mechanical ventilation (intubation), rendering them effectively
More news about: Laronix, Inc.
Mar 16, 2026, 10:00 ET Global AI Deploys the largest NVIDIA GB300 NVL72 Cluster in New York ; Plans Next to Deploy NVIDIA Vera Rubin NVL72 Systems
competitive edge doesn't become the market's baseline.""The NVIDIA Vera Rubin platform is engineered with extreme co-design across new six chips, to power agentic AI and reasoning-intensive workloads within a secure, sovereign infrastructure," said Dave Salvator, Director of Accelerated
More news about: Global AI
Mar 16, 2026, 09:21 ET LG ELEVATES HOME ENTERTAINMENT WITH UNRIVALLED VISUALS AND EXCITING, EXCLUSIVE STREAMING ACCESS
functionality across its diverse television lineup has just been boosted even further, with a new limited-time offer that bundles a number of its new TVs with a six-month MBC SHAHID subscription.
More news about: LG
Mar 16, 2026, 09:20 ET Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor
respite care.Hospice eligibility is based on a physician's determination that a patient is facing an advanced illness with a life expectancy of six months or less. Families and clinicians can request an evaluation or make a referral at 800.93.VITAS or by visiting VITAS.com, where support is available
More news about: VITAS Healthcare
Mar 16, 2026, 09:18 ET ONL Therapeutics Announces First European Patient Randomized in its Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
data from a Phase 1b study that demonstrated xelafaslatide to be generally safe and well tolerated with encouraging efficacy signals observed after six months. Xelafaslatide, which is delivered via intravitreal injection, will be studied across three experimental arms, including two dose levels and two
More news about: ONL Therapeutics
Mar 16, 2026, 09:04 ET Kinder Joy Unveils Unicorns & Racing Themed Collections to Ignite Kids' Imaginative Play
play experiences that spark creativity and turn a small surprise into a big imaginative journey."Kinder will launch two new collections every six months. Every toy is designed for mixing, matching, displaying, and can be brought to life through,
More news about: Ferrero North America
Mar 16, 2026, 09:00 ET CARROT CAKE JUST GOT THE LEVAIN BAKERY TREATMENT
YORK, March 16, 2026 /PRNewswire/ -- Levain Bakery, a New York City institution renowned for its iconic six-ounce cookies, debuts a new Carrot Cake Cookie for a limited time this spring. Inspired by the classic dessert and rooted in the bakery's 30-year tradition
More news about: Levain Bakery
Mar 16, 2026, 09:00 ET Doral Renewables Secures $525 Million of Surety-Backed Letter of Credit Financing
LLC. "We are particularly grateful to forge new cross-border financing relationships with the broker for these facilities, Howden CAP, as well as the six different international underwriters that participated collectively across these two facilities."Howden Capital Advisory and Placement (CAP) served
More news about: Doral Renewables LLC
Mar 16, 2026, 09:00 ET NATURAL BALANCE LAUNCHES BOLD NEW BRAND CAMPAIGN: 'THAT'S GOOD SH*T'
linked here), that features an energetic, six-year-old Australian labradoodle named, Quinn, and captures everyday rituals – a routine walk, a stop at the dog park – through the lens of a pet parent
More news about: Natural Balance Pet Foods, Inc
Mar 16, 2026, 09:00 ET Carolwood Estates launches its 2025 Annual Report
Carolwood represented six (60%) of them.In 2025,
More news about: Carolwood Estates
Mar 16, 2026, 09:00 ET Enchant Your Cup with Harry Potter® and Coffee mate® at The Butterbeer Cafe in NYC
proudly showcase their passion through innovative consumer products, and thrill at spectacular location-based experiences - including themed lands at six Universal Destinations and Experiences theme parks around the world. This expanding portfolio of Warner Bros. Discovery-owned Harry Potter and
More news about: Coffee mate®
Mar 16, 2026, 08:58 ET GDUSA Debuts the Sports Graphic Design Awards for A Creative Field AI Can't Replace
designers worldwide. It encourages designers with projects for professional, collegiate, esports, and amateur levels to apply. Entries are accepted across six core categories:Team & Event Brand Identity: Identity systems, marks, and branding that define teams, events, and sports properties.Marketing
More news about: Graphic Design USA
Mar 16, 2026, 08:54 ET Snuggle Me® Organic Launches the Infant Rocker After Rapid Limited-Edition Sellout
Snuggle Me Organic Infant Rocker. After a limited-edition release that sold out in just six days, the highly anticipated bouncer is now joining the brand's permanent collection. The Snuggle Me Infant Rocker offers a soothing place for
More news about: Snuggle Me Organic
Mar 16, 2026, 08:42 ET Empact Technologies Secures Six-Year Compliance Partnership with Maas Energy Works Supporting 56 Renewable Energy Projects
/PRNewswire/ -- Empact Technologies ("Empact"), a leading provider of clean energy tax credit compliance and risk management solutions, announced a six-year agreement with Maas Energy Works ("MEW"), the nation's largest dairy digester developer and operator, to provide prevailing wage and domestic content
More news about: Empact Technologies
Mar 16, 2026, 08:30 ET Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer
often diagnosed at an advanced stage, creating urgency in treatment planning. Platinum resistance, defined as disease progression or recurrence within six months of finishing first-line platinum-based chemotherapy, is estimated to affect 20-30% of patients with advanced HGSOC. For clinicians, understanding
More news about: Caris Life Sciences
Mar 16, 2026, 08:00 ET Registration Opens for the 2026 Texas Floral Expo
New this year, six concurrent spotlight presentations and eight optional hands-on workshops are organized into four categories to help attendees easily select the sessions
More news about: Texas State Florists’ Association
Mar 16, 2026, 08:00 ET Choice Hotel International's Ascend Collection Surpasses 500 Hotel Openings, Marking a Major Achievement for the Company's Growth in Upscale
Canada with the addition of six new properties in Québec.Landmark entry into
More news about: Choice Hotels International, Inc.
Mar 16, 2026, 08:00 ET Trademark Collection by Wyndham Marks Milestone, Surpasses 100 U.S. Hotels
is the world's largest hotel franchising company by the number of franchised properties, with over 8,300 hotels across approximately 100 countries on six continents. Through its network of approximately 869,000 franchised and affiliated rooms appealing to the everyday traveler, Wyndham commands a leading
More news about: Wyndham Hotels & Resorts
Mar 16, 2026, 08:00 ET Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
also initiate further trials in the near future in MDD, Alzheimer's and PTSD.The study will utilize a crossover design intended for multiple six-subject cohorts. Following screening, participants are randomized into one of two treatment sequences: AB (AL001 followed by lithium carbonate) or BA
More news about: Alzamend Neuro, Inc.
Mar 16, 2026, 07:00 ET Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multicultural workforce drawn from over 50 nations. For further information, please visit
More news about: Sun Pharmaceutical Industries Inc., USA (Sun Pharma)
Mar 16, 2026, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) is the first and only selective IL-13 inhibitor to deliver positive Phase 3 outcomes in patients aged six months to 18 years with moderate-to-severe atopic dermatitis
evaluating the efficacy and safety of EBGLYSS in pediatric patients with moderate-to-severe atopic dermatitis, including infants and children as young as six months. Participants (N=363) were randomized to receive placebo or a weight-based dose of EBGLYSS. Topical corticosteroids were required beginning two
More news about: Eli Lilly and Company
Mar 16, 2026, 04:30 ET VNET Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
which represents the equivalent of RMB1.02 (US$0.12) and RMB0.01 (US$0.00) per American depositary share ("ADS"), respectively. Each ADS represents six Class A ordinary shares. Diluted earnings/loss per share is calculated using adjusted net profit/loss attributable to ordinary shareholders divided by
More news about: VNET Group, Inc.
Mar 16, 2026, 02:00 ET Joybuy arrive en France avec des prix attractifs, des marques de confiance et une livraison le jour même !
quotidiennes exceptionnelles et à des promotions à durée limitée sur des produits issus de grandes marques.Dès aujourd'hui, Joybuy se lance sur six marchés européens : l'Allemagne, les Pays-Bas, la France, la Belgique, le Luxembourg et le Royaume-Uni.PARIS,
More news about: Joybuy
Mar 16, 2026, 02:00 ET Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
variant.BASEL, Switzerland, March 16, 2026 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 biomarker test – the first
More news about: Roche